The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy (NIVOTAX): A TTCC study.
 
Lara Iglesias
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Lilly; Merck; MSD; Roche; Sanofi
Travel, Accommodations, Expenses - Roche
 
Alberto Carral
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck KGaA; Sanofi/Aventis; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; Pierre Fabre; SERVIER
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst)
 
Marc Oliva Bernal
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Mirati Therapeutics
Travel, Accommodations, Expenses - MSD Oncology
Other Relationship - Bristol-Myers Squibb; Merck
 
Javier Martinez-Trufero
Consulting or Advisory Role - Eisai; PharmaMar; Sanofi
Research Funding - Blueprint Medicines (Inst); Lilly (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; PharmaMar; PharmaMar
 
Almudena García Castaño
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD; Novartis
 
Vanesa Gutierrez Calderon
No Relationships to Disclose
 
Beatriz Cirauqui
No Relationships to Disclose
 
Ana Medina
Honoraria - Bristol-Myers Squibb; Eisai; Eusa Pharma; Janssen-Cilag; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Janssen-Cilag; PharmaMar; Roche; Sanofi
Other Relationship - Novartis
 
Virginia Arrazubi
Speakers' Bureau - Bristol-Myers Squibb; MSD; SERVIER
Travel, Accommodations, Expenses - Merck
 
Gema Bruixola
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Merck
 
Pedro Perez
Honoraria - BMSi; Merck; MSD Oncology
Consulting or Advisory Role - BMSi; Merck; MSD Oncology
Speakers' Bureau - BMSi; Merck; MSD Oncology
Research Funding - BMSi; Merck; MSD Oncology
Travel, Accommodations, Expenses - BMSi; Merck; MSD Oncology
 
Neus Basté Rotllán
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck Serono; MSD
 
Ruth Alvarez
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
 
Laura Basterretxea
No Relationships to Disclose
 
Jordi Rubió-Casadevall
Consulting or Advisory Role - Novartis
 
Javier Caballero Daroqui
No Relationships to Disclose
 
Joaquina Martínez-Galán
No Relationships to Disclose
 
Julio Jose Lambea- Sorrosal
No Relationships to Disclose
 
Edel del Barco
No Relationships to Disclose
 
Ricard Mesia
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb